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Several studies have been done on E. coli alkaline phosphatase (AP) in regards to catalytic efficiency while varying pH [3,4,5,8].
This enzyme is pH dependent due to a serine residue in the active site that is necessary for catalysis. The mechanism for the
dephosphorylation that AP catalyzes uses proton exchange to increase the nucleophilicity of Ser-102 [8] (see Figure 3). The rate
limiting step for this reaction in acidic conditions (pH < 7.5) is dependent on the deprotonation of the serine nucleophile
(pKa~5.5); while in basic conditions (pH > 7.5), the rate limiting step is product release [5] (see Figure 3).
Most mutations of site Asp101 in E. coli alkaline phosphatase cause a decrease in catalytic efficiency due to the residue proximity
and stabilization of the neighboring alkoxide nucleophile Ser102. Similarly, we find mutation of aspartate-101 to histidine
(designed to decrease the 𝑝𝐾𝑎 of Ser102) shows a decrease in 𝑘𝑐𝑎𝑡 and an increase 𝐾𝑚 at pH 8.0, yielding a 26 fold decrease in
catalytic efficiency (kcat/Km). Histidine, with a physiologically titratable imidazole side chain, can provide stabilization of both the
reforming serine hydroxyl and the phosphate dianion product in its protonated state altering this basic limb (see Figure
4). Although introduction of the histidine yields an overall decrease in catalytic efficiency from wild type the introduction of a
residue with opposite charge when compared to D101 under physiological conditions, changes the activity profile to favor product
stabilization in this proposed AP mechanism. As pH increases this histidine is deprotonated and neutral and cannot provide
stabilization of the serine hydroxyl and phosphate dianion leaving group yielding a significant drop in catalytic activity as pH
increases from 7.4 to 10.0. Further investigation into the mechanistic and structural variations caused by this mutation will be
important in deciphering requirements for the evolution of a more promiscuous and catalytically efficient AP enzyme.
Mutant Plasmid Synthesis and Purification
• A plasmid for alkaline phosphatase was designed with single point mutation, primer obtained from IDT, and plasmid was
synthesized using modified QuikChange II Site-Directed Mutagenesis kit from Agilent technologies.
• E. coli was plated (Ampicillin (Amp) (125 µg/mL). DNA extraction and purification was done using the E.Z.N.A. Plasmid DNA
Mini Kit II Protocol- Spin Method from Omega bio-tek (low copy plasmid), and was inoculated (with 25mg/mL ampicillin)
overnight in LB medium.
Protein Expression and Purification
• DNA was transformed with BL21 cells (New England Biolabs); The DNA, with 500 µL of glucose rich media was incubated at
37℃ with shaking for 30 minutes. DNA was then plated (glucose rich media, agar, and ampicillin (100µg/mL)) and incubated at
37℃.
• A single colony was inoculated, then 5 mL of inoculation was transferred to 300 mL glucose rich media and ampicillin (100
µg/mL), and continued inoculation until O.D.600nm = 0.3-0.5.
• Then 100 mM IPTG was added, put at 37℃ with shaking for 6 hours. Spun down, brought cells up in hypertonic solution, flash
frozen in dry ice/isopropanol bath, thawed in 37℃ water bath, shook gently for 5 min, centrifuged for 20 minutes at 15,000 rpm,
decanted, and kept supernatant. Added 10 mL of ice cold water to resuspend pellet, spun for 20 minutes at 15,000 rpm, decanted
and kept supernatant, and supernatants were combined.
• Dialyzed with column buffer (20 mM Tris (pH 7.4), 200 mM NaCl) 4 times to achieve 0.01% sucrose concentration in protein
solution.
• Separation by Amylose resin column (New England Biolabs) (17 cm diameter, 7 cm height) at 25℃. Equilibrated column in column
buffer (3x vol., 1 mL/min), then loaded protein, washed with column buffer (~3x vol., until baseline A280nm). Eluted with column
buffer containing 10 mM maltose (~3x vol., until baseline).
• Small scale activity assay at 25℃ done with 100 µL total volume containing 90 µL reaction solution (10 mM Tris (pH 8.0), 50 mM
NaCl, 10 mM MgCl2, 100 µM ZnCl2, 1.0 mM PNPP) and 10 µL of fraction, watched for activity over 1 minute for each of the 94
fractions, in order to determine AP presence.
• An SDS PAGE gel (Biorad precast, 10% polyacrylamide bis glycine) was run in buffer (0.025 M Tris base, 0.192 M glycine, 0.1%
SDS) at 200 volts for 45 minutes. Prior to loading, samples were heated for 5 minutes at 90℃ in loading buffer (62.5 mM Tris-Cl
(pH 6.8), 10% (v/v) 2-mercaptoethanol, 5% (w/v) SDS, 50% (v/v) glycerol, 0.05% (w/v) bromophenol blue). Stained overnight at
25℃ (0.125% (w/v) Coomassie Brilliant Blue R250, 50% (v/v) methanol, 10% (v/v) acetic acid). De-stained for 4 hours at 25℃
(50% (v/v) methanol, 10% (v/v) acetic acid). Purity was deermined to be >98%.
• Pooled fractions 83-85, then dialyzed with dialysis buffer (10 mM Tris (pH 7.4), 50 mM NaCl, 10 mM MgCl2, 100 µM ZnCl2,
50% glycerol) 2 times in 4L for 1 week at 4℃, then stored at -20℃.
• Verified concentration of protein to be 2.632E-05 M by using a nanodrop and the molar extinction coefficient of 96,195 𝑀−1𝑐𝑚−1.
Kinetic Analysis
• Enzyme activity was measured by performing kinetic assays watching PNP formation (𝐴408𝑛𝑚) with tungstate inhibition (0.1 mM)
and enzyme at 25℃. Collected on VWR Up 1600 PC Spectrophotometer.
• Data analysis involved plotting initial velocity values to create a Michaelis-Menten plot. Michaelis-Menten plots were converted to
Hanes-Woolf plots in order to determine 𝑉𝑚𝑎𝑥 and 𝐾𝑚 (or 𝐾𝑚 apparent) values. Km (apparent) values were adjusted based on
estimated 𝐾𝑖 values based on 𝐾𝑖 pH dependence data found by [5] O’Brien & Herschlag.
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pH 𝑲𝒎 (M) 𝒌𝒄𝒂𝒕 (𝒔𝒆𝒄−𝟏) ൗ
𝒌𝒄𝒂𝒕
𝑲𝒎 (𝑴
−𝟏𝒔𝒆𝒄−𝟏)
7.4 *1.5 x 10-6 9.58 6.38 x 106
8.0 *4.71 x 10-6 5.97 1.26 x 106
9.0 1.20 x 10-5 31.32 2.61 x 106
9.5 1.24 x 10-4 48.94 3.95 x 105
10.0 **4.36 x 10-4 41.44 9.51 x 104
Figure 5. Hanes-Woolf plot showing D101H enzyme activity dependence on pH in the presence of
0.1mM tungstate inhibitor, where pNPP is the substrate used. 𝑅2 values for linear fit were as follows:
0.995 (pH 7.4), 0.997 (pH 8.0), 0.980 (pH 9.0), 0.954 (pH 9.5), 0.893 (pH 10.0).
Figure 1.  E. coli. alkaline phosphatase structure 
with tungstate inhibition. Generated from iMol.
3mL Assay without Tungstate 
inhibitor 
Reaction buffer—running 
concentration of 100 mM Tris 
(pH 7.4, 8)/CHES (pH 9, 9.5, 
10), 50 mM MgCl2, 0.5 M NaCl, 
50 uM ZnCl2
D101H enzyme (2.63 ×
10−8 𝑀)
5X pNPP solution (1.5μM-
10mM)
H2O
Figure 3. Proposed mechanism for AP catalyzed cleavage of phosphate
monoester substrates (O’Brien and Herschlag 2002). The acidic limb (pH<7.5)
of this mechanism is rate limited by the deprotonation of ser-102 while the basic
limb (pH>7.5) requires deprotonation of water, stabilization of the serine
hydroxide and phosphate dianion products, and release of product.
Table 2. D101H mutant pH dependence of 𝐾𝑚 , 𝑘𝑐𝑎𝑡 , and catalytic efficiency
( ൗ𝑘𝑐𝑎𝑡 𝐾𝑚 ).
3mL Assay with Tungstate 
inhibitor 
Reaction buffer—running 
concentration of 100 mM Tris 
(pH 7.4, 8)/CHES (pH 9, 9.5, 
10), 50 mM MgCl2, 0.5 M NaCl, 
50 uM ZnCl2
D101H enzyme (2.63 ×
10−8 M)
5X pNPP solution (1.5μM-
10mM)
H2O
0.1mM Tungstate inhibitor
• Mutation D101H shows a change in catalytic efficiency compared to wild type and D101A,
showing decreased efficiency, lower 𝑘𝑐𝑎𝑡 and lower affinity (see Table 3).
• From pH 7.4 to 10, an increase in 𝐾𝑚 and an increase in 𝑘𝑐𝑎𝑡 is observed (see Table 2),
which suggests an alteration of the basic limb of the pH dependent curve, which has been
related to change in the limiting step from serine hydroxyl deprotonation to product release
[5].
• Introducing a histidine at position 101 causes a shift in catalytic efficiency toward
physiological pH, most likely due to the protonation near lower pH conditions, where the
positive residue likely contributes to phosphate stabilization due to its proximity to the
active site, Ser-102, and Arg-166.
• Compared to other AP mutants that were altered at this Asp-101 site displayed a decrease in
catalytic efficiency from wild type, though not as severe as D101H (see Table 3).
• Although 𝑘𝑐𝑎𝑡 in D101A was increased compared to WT, 𝐾𝑚 was altered very similarly as
D101H. This shows that the two mutants affected catalytic efficiency largely due to the
change in charge on the residue (from negative to neutral for D101A, and from negative to
positive for D101H) (see Table 3).
• Histidine, with a physiologically titratable imidazole side chain, can provide stabilization of
both the reforming serine hydroxyl and the phosphate dianion product in its protonated
state altering this basic limb. Although introduction of the histidine yields an overall
decrease in catalytic efficiency from wild type the introduction of a residue with opposite
charge when compared to D101 under physiological conditions, changes the activity profile
to favor product stabilization in this proposed AP mechanism (see Figure 3).
• As pH increases this histidine is deprotonated and neutral and cannot provide stabilization
of the serine and phosphate dianion leaving group. This is why we see a significant drop in
catalytic activity as pH increases from 7.4 to 10.0 (see Table 2).
• The intricate electrostatic balance of the active site, although altered by the introduction of
histidine at pH 8.0, a pH typically showing maximum activity for alkaline phosphatase,
begins to recover its activity under physiologically relevant conditions with a 𝑘𝑐𝑎𝑡 within
error of WT activity at pH 8.0 and a binding affinity (𝐾𝑚 ) within 4-fold.
Enzyme 𝒌𝒄𝒂𝒕 (𝒔𝒆𝒄−𝟏) 𝑲𝒎 (M) ൗ
𝒌𝒄𝒂𝒕
𝑲𝒎 (𝑴
−𝟏𝒔𝒆𝒄−𝟏)
Fold increase/decrease 
from WT
Wild Type* 12 3.60 x 10-7 3.30 x 107 1
D101H 5.97 4.70 x 10-6 1.27 x 106 26 decrease
D101A* 36 3.60 x 10-6 9.90 x 106 3.33 decrease
Further studies at lower pH’s would indicate if a change is also made in the acidic limb of this
reaction mechanism that would be related to changes in the serine hydroxyl nucleophile. It is possible
that the neighboring positive charge on histidine would further decrease the pKa of the histidine.
Further studies could also examine more into the exact pH dependence mechanism for this mutant. Cd
analysis would allow for observation of any significant structural changes had occurred with this
mutation. Future 𝐾𝐼 studies looking at pH dependence would help support the product release theory.
Designing a non-radioactive, high sensitivity assay would allow for more direct measurements of
kinetic analysis.
Table 3. Comparison of alkaline phosphatase wild type and Asp-101 mutants at pH 8.
*Data retrieved from [7] Sunden F., et al. 2015. eLife. 1-31.
.
Table 1.1: Kinetic assay conditions 
without inhibitor
Table 1.2: Kinetic assay conditions 
with inhibitor
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• As pH increases, 𝑘𝑐𝑎𝑡 increases
• As pH increases, 𝐾𝑚 increases, meaning that affinity decreases
• As pH increases, catalytic efficiency decreases
• At pH 7.4, D101H has a 5 fold increase in catalytic efficiency compared to pH 8, a trend not 
seen in wild type
• D101H mutation has a lower 𝑘𝑐𝑎𝑡 and a higher 𝐾𝑚 than wild type at pH 8
• D101H mutation has a 26 fold decrease in catalytic efficiency compared to wild type at pH 8
Figure 2. Alkaline phosphatase active site showing phosphate binding near
important residues: Ser102, D101, and R166. Image obtained from [6] Peck et al.
Figure 4. pH dependence for catalytic efficiency with alkyl phosphate 
substrate 2-fluorethyl phosphate, yielding pka values of 5.5 and 8.0. Figure 
retrieved from [5] O’Brien & Herschlag. 
pKa 5.5                                                                                                                      pKa 8.0      
E-SerOH E-SerO- • RPO3
2- E-SerO-PO3
2- + H2O E-SerO
- • HPO4
2- E-SerO- + ROPO3
2-
Free Enzyme                    Substrate Bound                                Covalent Intermediate                         Product Stabilization                             Product Release
Acidic Limb (pH<7.5)                                                       Basic Limb (pH>7.5)
*𝐾𝐼 values were adjusted based on the difference between 𝐾𝐼 at ph 9.0 and 9.5.
** 𝐾𝑚(𝑎𝑝𝑝𝑎𝑟𝑒𝑛𝑡) value was used because no inhibition was seen at this pH.
